VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,268,111 | -30.5% | 927,562 | +1.7% | 0.00% | -33.3% |
| Q2 2023 | $14,778,462 | +416.6% | 911,688 | +430.6% | 0.00% | +200.0% |
| Q1 2023 | $2,860,803 | +140.1% | 171,820 | +35.5% | 0.00% | – |
| Q4 2022 | $1,191,751 | +245.4% | 126,782 | -0.0% | 0.00% | – |
| Q3 2022 | $345,000 | -5.7% | 126,796 | 0.0% | 0.00% | – |
| Q2 2022 | $366,000 | -81.2% | 126,796 | -80.5% | 0.00% | – |
| Q1 2022 | $1,947,000 | -50.6% | 648,871 | -24.4% | 0.00% | -100.0% |
| Q4 2021 | $3,945,000 | -35.5% | 857,774 | -11.9% | 0.00% | 0.0% |
| Q3 2021 | $6,114,000 | +2.1% | 973,507 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $5,988,000 | -5.4% | 999,801 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $6,330,000 | -16.7% | 1,000,844 | -25.9% | 0.00% | 0.0% |
| Q4 2020 | $7,601,000 | -5.9% | 1,350,166 | -2.7% | 0.00% | -50.0% |
| Q3 2020 | $8,076,000 | -21.4% | 1,387,545 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $10,274,000 | +174.3% | 1,424,968 | +78.0% | 0.00% | +100.0% |
| Q1 2020 | $3,746,000 | -42.9% | 800,582 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $6,555,000 | +14.9% | 817,385 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $5,704,000 | -10.6% | 829,101 | +7.8% | 0.00% | -50.0% |
| Q2 2019 | $6,381,000 | -15.2% | 768,866 | +1.6% | 0.00% | 0.0% |
| Q1 2019 | $7,524,000 | +34.9% | 756,950 | +3.8% | 0.00% | 0.0% |
| Q4 2018 | $5,576,000 | -48.0% | 728,958 | +18.5% | 0.00% | -33.3% |
| Q3 2018 | $10,713,000 | +129.0% | 614,963 | +24.8% | 0.00% | +200.0% |
| Q2 2018 | $4,678,000 | +1255.9% | 492,845 | +524.2% | 0.00% | – |
| Q1 2018 | $345,000 | +111.7% | 78,953 | +97.1% | 0.00% | – |
| Q4 2017 | $163,000 | +409.4% | 40,052 | +136.1% | 0.00% | – |
| Q3 2017 | $32,000 | +77.8% | 16,962 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | -28.0% | 16,962 | 0.0% | 0.00% | – |
| Q1 2017 | $25,000 | +25.0% | 16,962 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | -16.7% | 16,962 | 0.0% | 0.00% | – |
| Q3 2016 | $24,000 | +14.3% | 16,962 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | – | 16,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |